EPIC methylation array analysis revealed SRCIN1 hypermethylation in breast cancer patient plasma, and this marker could distinguish between healthy individuals and patients with varying disease stages, with methylation levels increasing with disease severity. Here, SRCIN1 is linked to breast carcinoma.